Alf I. Larsen

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 25, 2026

Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial Infarction.

Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial Infarction.

Journal: Clinical chemistry

Published: December 16, 2025

Heart failure etiology and lipoprotein subfractions: Insight from the SMARTEX-HF study.

Heart failure etiology and lipoprotein subfractions: Insight from the SMARTEX-HF study.

Journal: International journal of cardiology. Heart & vasculature

Published: December 15, 2025

Contrast dose determined by body weight and tube potential in coronary CT angiography improves attenuation consistency and reduces contrast dose.

Contrast dose determined by body weight and tube potential in coronary CT angiography improves attenuation consistency and reduces contrast dose.

Journal: European journal of radiology open

Published: November 18, 2025

Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.

Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population.

Journal: European heart journal

Published: November 14, 2025

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.

Journal: The New England journal of medicine

Published: September 01, 2025

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.

Journal: Circulation

Published: August 30, 2025

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.

Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.

Journal: Circulation

Published: June 23, 2025

Assessment of Guidewire-Induced Deviation in Fractional Flow Reserve: Impact of Lesion Morphology and Pressure Guidewire Malposition.

Assessment of Guidewire-Induced Deviation in Fractional Flow Reserve: Impact of Lesion Morphology and Pressure Guidewire Malposition.

Journal: International journal for numerical methods in biomedical engineering

Published: April 28, 2025

Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudy.

Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudy.

Journal: International journal of cardiology. Cardiovascular risk and prevention

Published: March 12, 2025

Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Journal: Journal of the American College of Cardiology

Published: February 06, 2025

Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials.

Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials.

Journal: European journal of preventive cardiology

Published: December 13, 2024

Showing 1-12 of 89

Last Updated: 09/26/2026